Clinical information such as age, sex, smoking, alcohol, body mass index (BMI), fasting state, tumor stage and node status was available for the majority of diagnostic samples, and the impact of these clinical factors on TRAF2 levels were studied. This evidence concerns the gene TRAF2 and neoplasm.